Do you want to be part of making a difference? Nykode Therapeutics ASA is growing, and we are now seeking a Senior Digital Accountant who can take lead with continuing to digitalize our accounting processes and systems. As our Senior Digital Accountant you will be part of our accounting team with the responsibilities and tasks that follows. Furthermore, you will be the administrator of our ERP system with focus on ensuring quality in the system. You will be part of developing and improving our department to become a forward-looking, value-creating and innovative accounting function.
The position is based at Forskningsparken in Oslo, and reports to the Accounting Manager.
Your main responsibilities:
- ERP administrator/ Super User ERP-system, (Xledger)
- Import/batch input to ERP-system
- Contact point accounting suppliers
- Ad-hoc accounting tasks
- Participation in audits and internal controls
- Support with monthly balance sheet reconciliation
- Participation in month end closing process
- Participation in development, implementation and follow-up of new finance routines, processes and policies within area of responsibility.
Your qualifications are:
- Higher degree in accounting, finance or audit, minimum bachelor’s degree
- 1+ years relevant experience
- Experience with ERP-systems and system development. Experience as a super user or system administrator is a must
- Fluent in English and Norwegian, both verbally and written
- Experience with Xledger is a must
Who are you?
When growing and building our teams, we look for the people inspired by our mission and those seeking to join a collaborative and value-based company culture. An eagerness to learn and continuously develop is a core characteristic of our highly skilled and competent individuals.
We are looking for someone who is self-driven and willing to go the extra mile to deliver quality results on time. You are interested in continuous improvements, streamlining processes and have a pragmatic approach in your way to achieve results.
To succeed in this role you must thrive in the border line between accounting and systems. You must have experience from accounting, and an interest in, and curiosity for ERP-systems. You are structured, solution oriented, service minded, and like a fast-paced environment. If you are also a team player and able to adapt to changes, this could be the right opportunity for you.
Why join our team?
At Nykode, we offer a fun, enthusiastic, dynamic and international working environment. The people are at the heart of our organization, which is why we always keep striving to offer a workplace where we cheer each other on and find motivation. Your skills and competencies are unique and to ensure continued development our aspiration is to provide you with good opportunities for personal and professional growth.
At Nykode we care about each other!
We are happy to arrange an informal chat. Feel free to contact Senior Advisor at Capus, Kjersti Kjelby Sundin on 90 10 22 99 or Advisor, Jenny Conradi on 90 83 30 14.
We look forward to hearing from you!
Nykode Therapeutics ASA is a listed, clinical-stage biopharmaceutical company founded in 2007, dedicated to the discovery and development of vaccines and novel immunotherapies.
Our bold aim is to generate game-changing therapeutics to treat cancers and infectious diseases with a high unmet medical need. With our unique and innovative modular vaccine technology, we’re specifically targeting antigens to Antigen Presenting Cells, which are essential for inducing rapid, strong and long-lasting immune responses.
We are more than 150 amazing multinational employees within medical-, development-, manufacturing-, bioinformatics-, research and support teams. We utilize the Nykode Therapeutics’ technology platform to generate novel treatments across therapeutics areas including oncology, infectious diseases, and immune tolerance. We closely collaborate with several pharmaceutical companies, and we are proud to have entered into a worldwide license and collaboration agreements with Genentech, a member of the Roche Group and Regeneron.